1. Home
  2. BEAM vs TOWN Comparison

BEAM vs TOWN Comparison

Compare BEAM & TOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • TOWN
  • Stock Information
  • Founded
  • BEAM 2017
  • TOWN 1998
  • Country
  • BEAM United States
  • TOWN United States
  • Employees
  • BEAM N/A
  • TOWN N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • TOWN Major Banks
  • Sector
  • BEAM Health Care
  • TOWN Finance
  • Exchange
  • BEAM Nasdaq
  • TOWN Nasdaq
  • Market Cap
  • BEAM 2.3B
  • TOWN 2.6B
  • IPO Year
  • BEAM 2020
  • TOWN 1999
  • Fundamental
  • Price
  • BEAM $25.14
  • TOWN $33.74
  • Analyst Decision
  • BEAM Strong Buy
  • TOWN Hold
  • Analyst Count
  • BEAM 12
  • TOWN 1
  • Target Price
  • BEAM $48.09
  • TOWN $41.00
  • AVG Volume (30 Days)
  • BEAM 2.3M
  • TOWN 267.3K
  • Earning Date
  • BEAM 11-04-2025
  • TOWN 10-22-2025
  • Dividend Yield
  • BEAM N/A
  • TOWN 3.21%
  • EPS Growth
  • BEAM N/A
  • TOWN 11.95
  • EPS
  • BEAM N/A
  • TOWN 2.23
  • Revenue
  • BEAM $55,701,000.00
  • TOWN $766,599,000.00
  • Revenue This Year
  • BEAM N/A
  • TOWN $23.63
  • Revenue Next Year
  • BEAM $19.01
  • TOWN $29.20
  • P/E Ratio
  • BEAM N/A
  • TOWN $15.08
  • Revenue Growth
  • BEAM N/A
  • TOWN 14.10
  • 52 Week Low
  • BEAM $13.53
  • TOWN $29.43
  • 52 Week High
  • BEAM $35.25
  • TOWN $38.28
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 58.18
  • TOWN 56.13
  • Support Level
  • BEAM $20.23
  • TOWN $31.97
  • Resistance Level
  • BEAM $22.72
  • TOWN $34.06
  • Average True Range (ATR)
  • BEAM 1.68
  • TOWN 0.69
  • MACD
  • BEAM 0.36
  • TOWN 0.17
  • Stochastic Oscillator
  • BEAM 97.41
  • TOWN 84.38

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

Share on Social Networks: